Stay updated on Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site interface update rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:21:12.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:50:44.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Version bump from v3.4.3 to v3.5.0; no visible changes to study details or page content are indicated.
    Difference
    0.1%
    Check dated 2026-03-19T06:28:01.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Updated from revision v3.4.2 to v3.4.3. This appears to be a minor internal version update with no visible changes to study details or user-facing features.
    Difference
    0.1%
    Check dated 2026-03-12T01:43:44.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, both as site-wide versioning updates that do not affect the trial details or data on this page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:35:47.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government funding–related notice about possible delays in updating information. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:18:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.